Primary Device ID | 00812101031216 |
NIH Device Record Key | 2ce99509-f539-4897-9bc1-89d2eff1ca14 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | ARK™ Methotrexate II Control |
Version Model Number | 5071-0003-02 |
Catalog Number | 5071-0003-02 |
Company DUNS | 164880598 |
Company Name | ARK DIAGNOSTICS INC |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | true |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 00812101031216 [Primary] |
LAO | Enzyme Immunoassay, Methotrexate |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2024-11-01 |
Device Publish Date | 2024-10-24 |
00812101031216 | ARK™ Methotrexate II Control is intended for use in quality control of the ARK Methotrexate II |
00812101031209 | ARK™ Methotrexate II Control is intended for use in quality control of the ARK Methotrexate II |
00812101031193 | ARK™ Methotrexate II Control is intended for use in quality control of the ARK Methotrexate II |